Our results also suggest that protective neuropeptides and trophic factors, such as PACAP, VIP or BDNF, may be considered as viable therapeutic targets to ameliorate the CNS damage caused by this debilitating form of SLE. The gene discussed is VIP; the disease is systemic lupus erythematosus.